Shares of MacroGenics, Inc. (NASDAQ: MGNX - Get Free Report) have been given an average rating of "H

MacroGenics is affirmed as a 'Buy' due to a de-risked operational runway and promising B7-H3 ADC pip

Interim Phase 1 results accepted for poster presentation at ESMO Congress 2026 Achieved pre-specifie

Does MacroGenics (MGNX) have what it takes to be a top stock pick for momentum investors? Let's find

ROCKVILLE, MD, July 02, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage

ROCKVILLE, MD, June 22, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage

ROCKVILLE, MD, May 14, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutica

MacroGenics (MGNX) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Esti

ROCKVILLE, Md., May 13, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage

Harmonic Inc (HLIT) rose in pre-market trading after beating earnings expectations & raising gui

•MacroGenics to receive $122. 5 million upfront payment from Bora upon closing•Transaction includes

MacroGenics (MGNX) doesn't possess the right combination of the two key ingredients for a likely ear

• MacroGenics receives $60 million cash payment from Sagard Healthcare Partners (Sagard), with the p

• Plan to resume enrollment in clinical study of lorigerlimab in gynecologic cancers   • On track to

Medtronic (NYSE: MDT - Get Free Report) and MacroGenics (NASDAQ: MGNX - Get Free Report) are both me

MacroGenics, Inc. (MGNX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

MacroGenics (MGNX) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Esti

ROCKVILLE, Md., March 09, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stag

ROCKVILLE, MD, Feb. 26, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutic

FDA has placed partial clinical hold on LINNET study of lorigerlimab in gynecologic cancer FDA has p

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earning

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the pu

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earni

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn

Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnin

US crude oil futures traded higher this morning on Wednesday. Investors, meanwhile, focused on some

  Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings fo

Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining

  On Tuesday, 951 companies hit new 52-week lows.

  During Monday's trading, 1214 companies set new 52-week lows.

  Monday's session saw 84 companies set new 52-week lows.

  During the Thursday's session, 100 stocks hit new 52-week lows.

  On Wednesday, 215 companies set new 52-week lows.

  On Tuesday, 540 companies set new 52-week lows.

  On Friday, 1043 companies hit new 52-week lows.

  During Thursday, 351 stocks hit new 52-week lows.

  During Wednesday's trading, 435 companies set new 52-week lows.

  Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to repo

  During Thursday, 849 stocks hit new 52-week lows.

  Wednesday's session saw 784 companies set new 52-week lows.